Related Scientific Literature
- Cross-reaction of sera from COVID-19 patients with SARS-CoV assays
- Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment
- Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
- Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer
- Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech)
- Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
- Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients
- Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
- Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
- Assay Techniques and Test Development for COVID-19 Diagnosis.
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs